In glioma, MEX3A upregulates CCL2, a chemokine known to support proliferation, angiogenesis, and immune evasion, leading to alteration of the tumor microenvironment (TME) and promoting tumorigenesis (23). The gene discussed is CCL2; the disease is central nervous system cancer.